Download PDF
Thromb Haemost 2009; 102(01): 173-175
DOI: 10.1160/TH09-02-0099
Letters to the Editor
Schattauer GmbH

Tissue factor +5466A>G polymorphism predicts plasma TF levels in subjects with cryptogenic ischaemic stroke

Daniel P. Potaczek
1   Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan
,
Monika Pieculewicz
2   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
,
Marta Mazur
2   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
,
Agnieszka Branicka
3   John Paul II Hospital, Cracow, Poland
,
Chiharu Nishiyama
1   Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan
,
Ko Okumura
1   Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan
,
Piotr Podolec
2   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
,
Anetta Undas
2   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
› Author Affiliations
Further Information

Publication History

Received: 17 February 2009

Accepted after minor revision: 01 April 2009

Publication Date:
24 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113: 722-731.
    CrossrefPubMedGoogle Scholar
  • 2 Steppich B, Mattisek C, Sobczyk D. et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005; 93: 35-39.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Siegbahn A, Johnell M, Sorensen BB. et al. Regulation of chemotaxis by the cytoplasmic domain of tissue factor. Thromb Haemost 2005; 93: 27-34.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Butenas S, Undas A, Gissel MT. et al. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008; 99: 142-149.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Ott I, Koch W, von Beckerath N. et al. Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis 2004; 177: 189-191.
    CrossrefPubMedGoogle Scholar
  • 6 Mälarstig A, Tenno T, Johnston N. et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 2005; 25: 2667-2672.
    CrossrefPubMedGoogle Scholar
  • 7 Undas A, Stepien E, Potaczek DP. et al. Tissue factor +5466A>G polymorphism determines thrombin formation following vascular injury and thrombinlowering effects of simvastatin in patients with ischemic heart disease. Atherosclerosis. 2008 e-pub ahead of print..
    PubMedGoogle Scholar
  • 8 Austin H, Chimowitz MI, Hill HA. et al. Genetics and Stroke in the Young Study Group. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002; 33: 2762-2768.
    CrossrefPubMedGoogle Scholar
  • 9 Botto N, Spadoni I, Giusti S. et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38: 2070-2073.
    CrossrefPubMedGoogle Scholar
  • 10 Offelli P, Zanchetta M, Pedon L. et al. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 2007; 98: 906-907.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Guercini F, Acciarresi M, Agnelli G. et al. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost 2008; 06: 549-554.
    CrossrefPubMedGoogle Scholar
  • 12 Terry CM, Kling SJ, Cheang KI. et al. Polymorphisms in the 5’-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost 2004; 02: 1351-1358.
    CrossrefPubMedGoogle Scholar